Cell adhesion and chemotaxis in prostate cancer metastasis to bone: A minireview

Prostate Cancer and Prostatic Diseases

Volumn 3, Issue 1, 2000, Pages 6-12

  Cooper, C R ^a   Pienta, K J ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Cell adhesion molecules; Chemoattractants; Cytokines; Human bone marrow endothelial cells; Prostate cancer cells

Indexed keywords

CELL ADHESION MOLECULE; CHEMOATTRACTANT;

ANIMAL CELL; BONE MARROW CELL; BONE METASTASIS; CANCER CELL; CANCER MODEL; CELL ADHESION; CHEMOTAXIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW;

EID: 0033866215     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500387     Document Type: Review

References (48)

1. Bone metastases - The clinical problem
2. Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone
3. Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone
4. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts
5. Selective stimulation of prostatic carcinoma cell proliferation by transferrin
6. Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment
7. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer
8. Mechanisms of bone metastasis
9. Mechanisms of preferential metastasis of breast cancer to bone (Review)
10. Migration of tumor cells to organ-derived chemoattractants
11. Mechanisms involved in the metastasis of cancer to bone
12. Effect of ostcoblast supernatants on cancer cell migration and invasion
13. Collagen and collagen-derived fragments are chemotactic for tumor cells
14. Partial characterization of a bone-derived chemotactic factor for tumor cells
15. Alendronate blocks metalloproteinase secretion and bone collagen I release by PC-3ML cells in SCID mice
16. Epidermal growth factor (EGF) promotes chemomigration of a human prostate tumor cell line, and EGF immunoreactive proteins are present at sites of metastasis in ther stroma of lymph nodes and medullary bone
17. Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function
18. Osteoblast conditioned media contained TGF-betal and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components
19. The effects of growth factors associated with osteoblassts on prostate carcinoma proliferation and chemotaxis: Implications for the development of metastatic disease
20. Osteonectin promotes prostate cancer cell migration and invasion: A possible mechanism for metastasis to bone
21. Mechanisms of tumor invasion and metastasis
22. Organ preference of metastasis: The role of organ-specifically modulated endothelial cells
23. Differential adhesion of metastatic rat mammary carcinoma cells to organ-derived microvessel endothelial cells and subendothelial matrix
24. Metastatic tumor cells adhere preferentially to the extracellular matrix underlying vascular endothelal cells
25. Adhesion and invasion potential of rat prostatic cancer cells: Correlation with metastic potential
26. Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix
27. Rat prostate adencarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells
28. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line
29. Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion
30. Fibronectin and its integrin receptors in cancer
31. RGD-recognizing integrins mediate interactions of human prostate carcinoma cells with endothelial cells in vitro
32. Induction of experimental bone metastasis in Mice by Transfection of integrin α4β1 into tumor cells
33. Phenotypic characteristics of cell lines derived form disseminated cancer cells in bone marrow of patients with solid epithelial tumors: Establishment of working models for human micrometastases
34. Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell lines
35. Expression of cellular adhesion molecules on human prostate tumor cell lines
36. Quantification of integrin subunits on human prostatic cell lines-comparison of nontumorigenic and tumorigenic lines
37. Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the alpha 2 beta 1 integrin
38. Transforming growth factor-beta upregulates the integrin-mediated adhesion of human prostatic carcinoma cells to type I collagen
39. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model
40. The development of a model for the homing of multiple myeloma cells to human bone marrow
41. A fluorescent orthotopic bone metastasis model of human prostate cancer
42. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone
43. An experimental model of bone metastasis by human lung cancer cells: The role of parathyroid hormone-related protein in bone metastasis
44. A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice
45. Role of the vertebral venous system in metastatic spread of cancer cells to the bone
46. Preclinical models of prostate cancer
47. Metastatic prostate cancer in a transgenic mouse